Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Stock indices provide benchmarks and a lens into market trends. This overview explains their purpose and how investors leverage them.
16,698 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...
Nuclear energy is reclaiming attention as a reliable, low-emission power source. Here are three top picks that could ...
A respected wealth manager disclosed a fresh stake in Burke & Herbert Financial Services. This article explains what ...
Premium cardholders and broad payment networks offer two distinct paths to ride consumer spending. Explore how Americ...
Traders are coalescing around MANGOS stocks as AI-driven catalysts lift a new set of winners. The shift hints at a br...
Chipmakers retreat after Samsung delivers mixed earnings, triggering a broader sector reset. Intel and Applied Materi...
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
A surge in demand for precision long-range rifles and components is reshaping defense investing. The niche market is ...
International stocks keep crushing U.S. markets, fueling a rotation into developed economies. A low-cost ETF offers a...
May's inflation outlook from the Federal Reserve hints at bigger moves for markets. This guide explains what that mea...
A Goldman Sachs strategist says the AI boom is turning into a market become ‘rubber band’ moment, as cheap software d...